Valerio Therapeutics Reports Full Year 2023 Financial Result

30.04.2024 - Regulatory News: Valerio Therapeutics S.A. (Euronext Growth Paris: ALVIO), hereafter “Valerio Therapeutics” or the “Company”), a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA Damage ...

Related Keywords

San Antonio , Texas , United States , American , Robert Coleman , Nicolas Trebouta , American Association For Cancer Research , Company Group , Next Oncology , Valerio Therapeutics , Targeting Multiple Proteins , Repair Pathways , Inhibiting Different , American Association , Cancer Research , Investigational New Drug , Annual General Meeting , Euronext Growth Paris , Onxeo Chart , Nxeo Kurs , Nxeo Aktie ,